Finally, it was shown that treatment with decitabine (5‐aza‐2′‐deoxycytidine, DAC) inhibits the DNA methylation of the DAPK1 promoter and restores DAPK1 expression in lung cancer cell lines (Tang et al, 2004). This evidence concerns the gene DAPK1 and lung cancer.